[211At]NaAt can be effective in patients refractory to radioactive iodine. (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

[211At]NaAt can be effective in patients refractory to radioactive iodine.

Caption

Figure: (Upper) Graphical abstract illustrating the concept of targeted alpha therapy using [211At]NaAt in patients with radioactive iodine--refractory differentiated thyroid cancer (DTC). (Lower) Representative 131I planar and SPECT/CT images in patient with follicular thyroid cancer with multiple bone metastases after administration of [211At]NaAt (3.5 MBq/kg). 131I accumulation in lumbar spine and sacral metastases almost disappeared over time.

Credit

Image created by Watabe T, et al., The University of Osaka, Japan.

Usage Restrictions

Please give appropriate credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.